These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study. Yang H; Peng Q; Yin L; Li S; Shi J; Zhang Y; Lu X; Shu X; Zhang S; Wang G Arthritis Res Ther; 2017 Nov; 19(1):259. PubMed ID: 29178913 [TBL] [Abstract][Full Text] [Related]
4. [Myositis specific autoantibodies as a new diagnostic criterion for idiopathic inflammatory myopathies]. Kowalska-Oledzka E; Stern LZ Neurol Neurochir Pol; 2000; 34(2):339-47. PubMed ID: 10962726 [TBL] [Abstract][Full Text] [Related]
5. Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort. Tarricone E; Ghirardello A; Rampudda M; Bassi N; Punzi L; Doria A J Immunol Methods; 2012 Oct; 384(1-2):128-34. PubMed ID: 22884621 [TBL] [Abstract][Full Text] [Related]
6. Advances in serological diagnostics of inflammatory myopathies. Benveniste O; Stenzel W; Allenbach Y Curr Opin Neurol; 2016 Oct; 29(5):662-73. PubMed ID: 27538058 [TBL] [Abstract][Full Text] [Related]
11. The clinico-serological spectrum of overlap myositis. Fredi M; Cavazzana I; Franceschini F Curr Opin Rheumatol; 2018 Nov; 30(6):637-643. PubMed ID: 30074509 [TBL] [Abstract][Full Text] [Related]
12. Myositis Autoantigen Expression Correlates With Muscle Regeneration but Not Autoantibody Specificity. Pinal-Fernandez I; Amici DR; Parks CA; Derfoul A; Casal-Dominguez M; Pak K; Yeker R; Plotz P; Milisenda JC; Grau-Junyent JM; Selva-O'Callaghan A; Paik JJ; Albayda J; Corse AM; Lloyd TE; Christopher-Stine L; Mammen AL Arthritis Rheumatol; 2019 Aug; 71(8):1371-1376. PubMed ID: 30861336 [TBL] [Abstract][Full Text] [Related]
13. Myositis specific autoantibodies: changing insights in pathophysiology and clinical associations. Hengstman GJ; van Engelen BG; van Venrooij WJ Curr Opin Rheumatol; 2004 Nov; 16(6):692-9. PubMed ID: 15577606 [TBL] [Abstract][Full Text] [Related]
14. The role of cancer-associated autoantibodies as biomarkers in paraneoplastic myositis syndrome. Lu X; Peng Q; Wang G Curr Opin Rheumatol; 2019 Nov; 31(6):643-649. PubMed ID: 31369431 [TBL] [Abstract][Full Text] [Related]
15. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Love LA; Leff RL; Fraser DD; Targoff IN; Dalakas M; Plotz PH; Miller FW Medicine (Baltimore); 1991 Nov; 70(6):360-74. PubMed ID: 1659647 [TBL] [Abstract][Full Text] [Related]
16. Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays. Damoiseaux J; Vulsteke JB; Tseng CW; Platteel ACM; Piette Y; Shovman O; Bonroy C; Hamann D; De Langhe E; Musset L; Chen YH; Shoenfeld Y; Allenbach Y; Bossuyt X Autoimmun Rev; 2019 Mar; 18(3):293-305. PubMed ID: 30639643 [TBL] [Abstract][Full Text] [Related]
17. Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy. Selva-O'Callaghan A; Labrador-Horrillo M; Solans-Laque R; Simeon-Aznar CP; Martínez-Gómez X; Vilardell-Tarrés M Arthritis Rheum; 2006 Oct; 55(5):791-8. PubMed ID: 17013837 [TBL] [Abstract][Full Text] [Related]
18. Management of Interstitial Lung Disease in Patients With Myositis Specific Autoantibodies. Mecoli CA; Christopher-Stine L Curr Rheumatol Rep; 2018 Apr; 20(5):27. PubMed ID: 29637383 [TBL] [Abstract][Full Text] [Related]